相关实验视频
Updated: May 21, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.3K
对tau聚合的不同影响和对疾病进展的影响
Meaghan Van Alstyne1,2, James Pratt1, Roy Parker3,2,4
1Department of Biochemistry, University of Colorado Boulder, Boulder, Colorado 80301, USA.
Genes & development
|March 20, 2025
概括
陶蛋白错误折叠和聚合成纤维素驱动神经退行性疾病. 本综述探讨了影响陶聚合及其"类"传播的生物化学和细胞因素,为治疗策略提供了信息.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 细胞生物学 细胞生物学
背景情况:
- 陶蛋白本质上是无序的,易于在神经退行性条件下形成纤维状聚合物.
- 错折是受生物化学和细胞因素影响的平衡,导致纤维细胞的形成和传播.
- 病理与阿尔茨海默氏症等疾病有关,并通过"类"传播促进疾病的进展.
研究的目的:
- 审查调节陶聚合的生物化学和细胞途径.
- 讨论这些途径对神经退行性疾病病理生物学的影响.
- 探索潜在的定向治疗方法.
主要方法:
- 对影响陶聚合的生化和细胞机制的文献综述.
- 对影响纤维素形成,结构和传播的因素的分析.
- 讨论影响病理的细胞过程和微环境相互作用.
主要成果:
- 生物化学因素 (离子条件,PTM,共因子) 调节纤维的形成和结构.
- 细胞过程 (稳定性,清除,运输) 显著影响tau的聚合.
- 神经元-质相互作用和微环境影响了神经元内的条件和毒性.
结论:
- 了解tau聚合途径对于破译神经退行性疾病机制至关重要.
- 纤维细胞的传播表明"子样"的传播有助于疾病的进展.
- 准生物化学和细胞通路为新的定向疗法提供了潜力.
相关概念视频
Amyloid Fibrils
9.1K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.1K
Alzheimer's Disease: Overview
405
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
405

